Category: News WellSyndicate content

Content tagged to appear in the middle column of the home page

Vital Therapies aims even lower with $12-per-share IPO | MassDevice.com On Call

April 18, 2014 by Arezu Sarvestani

Bio-artificial liver maker Vital Therapies takes its IPO even lower, now planning to open at $12 per share.

MassDevice.com On Call

MASSDEVICE ON CALL — California biotherapeutics company Vital Therapies dropped its per-share price even lower, opening today at $12 per share in the hopes of raising $54 million. Shares are slated to open today on the Nasdaq market under the symbol "VTL."

MassDevice.com +3 | The top 3 medtech stories for Apr. 17, 2014

April 17, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Cardica hopes to raise $44M in public offering

April 17, 2014 by Arezu Sarvestani

California surgical devices maker Cardica details a public offering of common and preferred stock aimed at raising $43.9 million to support U.S. sales and marketing efforts.

Cardica hopes to raise $44M in public offering

Cardica unveiled the details of an upcoming public offering of stock, aimed at raising $43.9 million to support commercial efforts for the company's MicroCutter XCHANGE 30 minimally invasive stapling system.

Cardiac Dimensions closes $20M equity round

April 17, 2014 by Brad Perriello

Cardiac Dimensions raises $20 million from a syndicate of international investors for its Carillon mitral valve implant.

Cardiac Dimensions closes $20M equity round

Cardiac Dimensions said it raised $20 million from a syndicate of international investors for its Carillon mitral valve implant.

M.H. Carnegie & Co. and Lumira Capital led the round for Kirkland, Wash.-based Cardiac Dimensions, according to a press release. Investors in Australia, the U.S. and Canada also participated, the company said.

Philips takes down Ohio manufacturing following inspection

April 17, 2014 by Arezu Sarvestani

Philips voluntarily suspends manufacturing at an Ohio facility after an FDA investigation turns up "certain issues in the general area of manufacturing process controls."

Philips takes down Ohio PET/CT manufacturing following inspection

Philips Healthcare (NYSE:PHG) halted work at an Ohio manufacturing facility after an FDA inspection turned up some concerns with process controls, a company spokesman confirmed with MassDevice.com today.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp